Table 3 Demographic information of studied patient
Methods | Culture positive | PCR positive | tcdB PCR positive | tcdB LAMP positive |
|---|---|---|---|---|
Number | ||||
Gender | ||||
Male (22) | 4 (4/22) | 7 (7/22) | 6 (6/22) | 6 (6/22) |
Female (28) | 6 (6/28) | 10 (10/28) | 7 (7/28) | 9 (9/28) |
Antibiotic | ||||
Consumption (31) | 9 (9/31) | 16 (16/31) | 13 (13/31) | 14 (14/31) |
No - consumption (19 | 1(1/19) | 1 (1/19) | 0 (0/19) | 1 (1/19) |
Age (year) | ||||
1–20 (10) | 1 (1/10) | 1 (1/10) | 0 (0/10) | 1 (0/10) |
21–30 (12) | 1 (1/12) | 4 (3/12) | 2 (2/12) | 2 (3/12) |
31–40 (11) | 1 (1/11) | 2 (2/11) | 2 (2/11) | 2 (2/11) |
41–50 (8) | 3 (3/8) | 5 (5/8) | 4 (4/8) | 5 (5/8) |
≤ 50 (9) | 4( 4/9) | 5 (5/9) | 5 (4/9) | 5 (5/9) |
Hospitalization time | ||||
< 1week (13) | 1 (2/13) | 2 (2/13) | 1 (3/13) | 1 (1/13) |
1–2 week (22) | 4 (4/22) | 5 (5/22) | 4 (4/22) | 4 (4/22) |
> 2week (15) | 5 (3/12) | 10 (10/12) | 8 (8/12) | 10 (10/12) |
Hospital departments | ||||
Gastrointestinal (19) | 4 (4/19) | 7 (7/19) | 7 (7/19) | 7 (7/19) |
Infectious (20) | 5 (5/20) | 6 (6/20) | 5 (5/20) | 5 (5/20) |
Transplant (6) | 1 (1/6) | 3 (3/6) | 1 (1/6) | 3 (3/6) |
Emergency (5) | 0 (0/5) | 1 (1/5) | 0 (0/5) | 0 (0/5) |